id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-D-0083-0002,FDA,FDA-2024-D-0083,Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public Health Response in the Absence of a Declaration under Section 564; Draft Guidance for Laboratory Manufacturers and Food and Drug Administration Staff - Draft Guidance,Other,Guidance,2024-05-06T04:00:00Z,2024,5,2024-05-06T04:00:00Z,2024-07-06T03:59:59Z,2024-11-12T22:34:02Z,,1,0,0900006486543952
FDA-2024-D-0083-0001,FDA,FDA-2024-D-0083,"Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate
Public Health Response in the Absence of a Declaration Under Section 564; Draft Guidance for Laboratory Manufacturers and Food and Drug Administration Staff; Availability",Proposed Rule,GDL Guidance,2024-05-06T04:00:00Z,2024,5,2024-05-06T04:00:00Z,,2024-05-06T14:30:21Z,2024-08934,0,0,09000064865425b3